by Plus Therapeutics | Dec 23, 2024 | Uncategorized
🎄 Happy Holidays from Plus Therapeutics! 🎄 As the end of year year approaches, the Plus Therapeutics team wants to extend our warmest holiday greetings to all of our patients, partners, and supporters. We are taking some time this week to relax and recharge with our...
by Plus Therapeutics | Dec 19, 2024 | GBM
🎗️ Now Streaming: ReSPECT-GBM Patient Story – Jim’s Journey as a Recurrent Glioblastoma Survivor Watch Jim’s Inspiring Story Now on YouTube: Watch Jim’s Story Dr. Jim Stockand, a dedicated educator with a PhD in Physiology, has devoted the past 24 years to...
by Plus Therapeutics | Dec 18, 2024 | GBM
❗NEW CLINICAL TRIAL SITE NOW ENROLLING PATIENTS: ReSPECT-GBM at North Shore University Hospital❗ We are excited to announce a new clinical trial investigation site for the ReSPECT-GBM clinical trial: North Shore University Hospital @NorthwellHealth in New York. Under...
by Plus Therapeutics | Dec 17, 2024 | LM
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data at 2024 San Antonio Breast Cancer Symposium (SABCS) ICYMI: Plus Therapeutics presented our ReSPECT-LM Phase 1 interim data for Breast Cancer patients with Leptomeningeal Metastases at the 2024 San...
by Plus Therapeutics | Dec 16, 2024 | GBM
COMING SOON: A Glioblastoma Survivor’s Journey with ReSPECT-GBM This week, we are thrilled to share a BRAND NEW patient testimonial from Jim, a courageous individual who has been navigating the challenges of recurrent glioblastoma. In this powerful video, Jim...
Recent Comments